A high platelet count, called thrombocytosis, means your blood contains more than 450,000 platelets per microliter. The normal range is 150,000 to 400,000. In the vast majority of cases, a high count is your body’s reaction to something else going on, like an infection, inflammation, or iron deficiency. Less commonly, it signals a problem in the bone marrow itself.
Reactive Causes: The Most Common Explanation
Most elevated platelet counts are “reactive,” meaning the bone marrow is responding to a signal from somewhere else in the body. The key player is an inflammatory molecule called IL-6, which tells the liver to ramp up production of the hormone that stimulates platelet-making cells. Anything that raises IL-6 levels can push your platelet count up. This is why a single high reading after a bad cold or a surgery doesn’t necessarily point to a serious problem.
The most common reactive triggers include:
- Acute infections. Bacterial infections like pneumonia, viral illnesses, and chronic infections such as tuberculosis all drive platelet production through inflammation.
- Chronic inflammatory diseases. Rheumatoid arthritis, inflammatory bowel disease, celiac disease, and sarcoidosis keep IL-6 elevated for long periods, which can keep platelet counts persistently high.
- Iron deficiency. Low iron directly alters the cells in bone marrow that produce platelets, pushing them to mature faster and produce more. This happens through a completely separate pathway from the usual hormonal signals, which is why iron-deficient patients can have high platelets even without obvious inflammation.
- Surgery or tissue damage. Major trauma, burns, or any significant tissue injury triggers a temporary spike.
- Spleen removal. The spleen normally stores about a third of your platelets. After it’s removed, platelet counts typically peak around day 7, often reaching 549,000 or higher, then gradually settle. By 30 to 60 days post-surgery, the median count drops to around 337,000, though it may stay mildly elevated long-term.
Cancer as a Trigger
Some solid tumors produce excess IL-6 as part of their growth, which raises platelet counts as a side effect. This is called paraneoplastic thrombocytosis, and it can sometimes be the first clue that a cancer exists. The cancers most associated with this include lung, ovarian, colorectal, gastric, renal, and prostate cancers, as well as mesothelioma.
The prevalence varies by cancer type. In large studies, about 16 to 32 percent of lung cancer patients had elevated platelets at diagnosis. For mesothelioma, the figure was nearly 55 percent. In ovarian cancer, roughly 20 percent of patients presented with high counts. Across these cancers, elevated platelets at diagnosis consistently correlate with worse outcomes, which is why doctors take unexplained thrombocytosis seriously, particularly in older adults or people with other concerning symptoms like weight loss or fatigue.
Bone Marrow Disorders
When no reactive cause explains a persistently high platelet count, the problem may originate in the bone marrow itself. This is called clonal (or primary) thrombocytosis. The most well-known form is essential thrombocythemia, a condition where the bone marrow overproduces platelets due to a genetic mutation in blood-forming stem cells.
About 60 percent of people with essential thrombocythemia carry a specific mutation in the JAK2 gene, which essentially leaves the “on switch” for platelet production stuck in the active position. Another 4 percent have a mutation in the MPL gene. A smaller group carries mutations in the CALR gene. Some patients have none of these, which makes diagnosis more challenging. Other bone marrow conditions, including polycythemia vera and certain types of myelofibrosis, can also cause high platelet counts.
How Doctors Figure Out the Cause
The diagnostic process starts with confirming the count is genuinely elevated, usually by examining a blood smear under a microscope. Automated counters occasionally misread cell fragments or clumps as platelets, so visual confirmation matters.
From there, the goal is distinguishing a reactive cause from a bone marrow problem. Doctors typically check inflammatory markers like C-reactive protein (CRP), ferritin, and sedimentation rate. These tend to be significantly elevated in reactive thrombocytosis but normal in bone marrow disorders. Iron studies help identify iron deficiency as a contributor. If the platelet count stays high after treating an obvious cause, like resolving an infection or correcting iron levels, that’s a red flag for something clonal.
When a bone marrow disorder is suspected, genetic testing for the JAK2, CALR, and MPL mutations is the next step, sometimes followed by a bone marrow biopsy. The diagnosis ultimately depends on piecing together lab results, identifying or ruling out an underlying cause, and watching whether the count normalizes with treatment of that cause.
When a High Count Becomes Risky
Reactive thrombocytosis rarely causes problems on its own. Your platelets may be elevated, but they function normally, and the count drops once the underlying trigger is addressed.
Clonal thrombocytosis is a different story. In essential thrombocythemia, the risk of both blood clots and bleeding follows a U-shaped curve. Clotting risk rises as counts climb above 450,000, but paradoxically, bleeding risk also increases at very high levels. Counts above 1,000,000 per microliter are considered extreme thrombocytosis, though recent research suggests the bleeding risk at that level may be lower than previously thought. The real danger depends less on the number itself and more on the underlying biology, including which genetic mutation is present and whether someone has other cardiovascular risk factors.
People with clonal thrombocytosis may experience vasomotor symptoms like headaches, visual changes, lightheadedness, or a burning sensation in the hands and feet. These happen because overactive platelets can form tiny clumps in small blood vessels. Reactive thrombocytosis almost never produces these symptoms.
Iron Deficiency Deserves Special Attention
Iron deficiency is worth singling out because it’s extremely common, easily missed, and highly treatable. Research shows that low iron directly changes how platelet-producing cells in the bone marrow behave, pushing them to mature faster and increase their internal complexity. This happens independently of the usual growth signals, meaning standard hormone levels may look normal even while the bone marrow is overproducing platelets.
This is particularly relevant for women with heavy menstrual periods, people with undiagnosed celiac disease, or anyone with chronic low-grade blood loss from the GI tract. Correcting the iron deficiency typically brings the platelet count back to normal, sometimes making it the simplest “fix” for what initially looks like a worrying lab result.